O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.91B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$139M
2
+$132M
3
+$110M
4
PFE icon
Pfizer
PFE
+$98.3M
5
GILD icon
Gilead Sciences
GILD
+$85.6M

Top Sells

1
+$372M
2
+$99.8M
3
+$98.1M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$93.8M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$68M

Sector Composition

1 Healthcare 97.58%
2 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$370M 6.22%
3,287,400
-55,700
2
$212M 3.55%
9,614,280
3
$201M 3.38%
8,327,691
-2,660,253
4
$200M 3.36%
7,406,307
5
$199M 3.35%
2,713,377
+665,480
6
$186M 3.13%
2,071,385
+408,800
7
$175M 2.95%
737,400
-45,700
8
$168M 2.83%
13,822,463
9
$166M 2.79%
5,548,326
10
$158M 2.66%
4,847,300
+172,500
11
$152M 2.55%
480,400
+415,900
12
$139M 2.34%
+4,673,850
13
$138M 2.32%
2,474,800
+774,800
14
$123M 2.06%
2,745,327
15
$110M 1.85%
1,471,100
+1,145,000
16
$110M 1.84%
+348,145
17
$109M 1.84%
1,423,300
+82,700
18
$101M 1.7%
4,004,442
19
$100M 1.69%
225,918
20
$100M 1.68%
1,155,015
+219,045
21
$99.9M 1.68%
3,347,000
+906,387
22
$98.3M 1.65%
+3,174,753
23
$91M 1.53%
1,352,000
+412,400
24
$89.9M 1.51%
638,558
-473,356
25
$88.3M 1.48%
902,449
+136,400
1
2 3 4 5